nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Metolazone—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Metolazone—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Metolazone—Dry skin—Betamethasone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Metolazone—Dry skin—Dexamethasone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Metolazone—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Metolazone—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Metolazone—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Metolazone—Purpura—Prednisone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Metolazone—Lethargy—Prednisone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Metolazone—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Metolazone—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Metolazone—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Metolazone—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00418	0.00418	CcSEcCtD
Metolazone—Dry skin—Prednisone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Metolazone—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Metolazone—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Metolazone—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Metolazone—Abdominal distension—Prednisone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Metolazone—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Metolazone—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Metolazone—Lethargy—Methotrexate—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Metolazone—Pancreatitis—Prednisone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Metolazone—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Metolazone—Vision blurred—Prednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Metolazone—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Metolazone—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Metolazone—Malaise—Prednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Metolazone—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Metolazone—Vertigo—Prednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Metolazone—Syncope—Prednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Metolazone—Back pain—Triamcinolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Metolazone—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Metolazone—Hypertension—Prednisolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Metolazone—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Metolazone—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Metolazone—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Metolazone—Discomfort—Prednisolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Metolazone—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Metolazone—Malaise—Triamcinolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Metolazone—Malaise—Methylprednisolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Metolazone—Vertigo—Triamcinolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Metolazone—Syncope—Triamcinolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Metolazone—Vertigo—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Metolazone—Syncope—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Metolazone—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Metolazone—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Metolazone—Shock—Prednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Metolazone—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Metolazone—Cough—Triamcinolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Metolazone—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Metolazone—Hypertension—Triamcinolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Metolazone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Metolazone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Metolazone—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Metolazone—Drowsiness—Methotrexate—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Metolazone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Metolazone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Metolazone—Discomfort—Triamcinolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Metolazone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Metolazone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Metolazone—Malaise—Dexamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Metolazone—Malaise—Betamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Metolazone—Vertigo—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Metolazone—Vertigo—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Metolazone—Syncope—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Metolazone—Syncope—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Metolazone—Shock—Triamcinolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Metolazone—Insomnia—Prednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Metolazone—Shock—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Metolazone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Metolazone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Metolazone—Epistaxis—Methotrexate—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Metolazone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Metolazone—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Metolazone—Hypertension—Dexamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Metolazone—Hypertension—Betamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Metolazone—Anxiety—Dexamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Metolazone—Anxiety—Betamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Metolazone—Discomfort—Dexamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Metolazone—Discomfort—Betamethasone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Metolazone—Pain—Prednisolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Metolazone—Hepatitis—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Metolazone—Vision blurred—Prednisone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Metolazone—Insomnia—Triamcinolone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Metolazone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Metolazone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Metolazone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Metolazone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Metolazone—Anaemia—Prednisone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Metolazone—Shock—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Metolazone—Shock—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Metolazone—Agitation—Prednisone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Metolazone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Metolazone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Metolazone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Metolazone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Metolazone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Metolazone—Malaise—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Metolazone—Vertigo—Prednisone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Metolazone—Syncope—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Metolazone—Tinnitus—Methotrexate—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Metolazone—Anorexia—Dexamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Metolazone—Anorexia—Betamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Metolazone—Urticaria—Prednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Metolazone—Fatigue—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Metolazone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Metolazone—Pain—Triamcinolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Metolazone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Metolazone—Hypertension—Prednisone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Metolazone—Chills—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Metolazone—Arthralgia—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Metolazone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Metolazone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Metolazone—Anxiety—Prednisone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Metolazone—Insomnia—Dexamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Metolazone—Insomnia—Betamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Metolazone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Metolazone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Metolazone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Metolazone—Discomfort—Prednisone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Metolazone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Metolazone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Metolazone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Metolazone—Urticaria—Triamcinolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Metolazone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Metolazone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Metolazone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Metolazone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Metolazone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Metolazone—Back pain—Methotrexate—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Metolazone—Fatigue—Dexamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Metolazone—Fatigue—Betamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Metolazone—Shock—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Metolazone—Pain—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Metolazone—Pain—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Metolazone—Vision blurred—Methotrexate—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Metolazone—Anorexia—Prednisone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Metolazone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Metolazone—Anaemia—Methotrexate—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Metolazone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Metolazone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Metolazone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Metolazone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Metolazone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Metolazone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Metolazone—Malaise—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Metolazone—Vertigo—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Metolazone—Leukopenia—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Metolazone—Urticaria—Dexamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Metolazone—Urticaria—Betamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Metolazone—Dizziness—Prednisolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Metolazone—Asthenia—Triamcinolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Metolazone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Metolazone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Metolazone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Metolazone—Insomnia—Prednisone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Metolazone—Paraesthesia—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Metolazone—Pruritus—Triamcinolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Metolazone—Cough—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Metolazone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Metolazone—Dyspepsia—Prednisone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Metolazone—Arthralgia—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Metolazone—Chest pain—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Metolazone—Decreased appetite—Prednisone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Metolazone—Rash—Prednisolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Metolazone—Dermatitis—Prednisolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Metolazone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Metolazone—Fatigue—Prednisone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Metolazone—Headache—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Metolazone—Discomfort—Methotrexate—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Metolazone—Constipation—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Metolazone—Dizziness—Triamcinolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Metolazone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Metolazone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Metolazone—Asthenia—Dexamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Metolazone—Asthenia—Betamethasone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Metolazone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Metolazone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Metolazone—Nausea—Prednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Metolazone—Pruritus—Betamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Metolazone—Pruritus—Dexamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Metolazone—Vomiting—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Metolazone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Metolazone—Rash—Triamcinolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Metolazone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Metolazone—Anorexia—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Metolazone—Rash—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Metolazone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Metolazone—Urticaria—Prednisone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Metolazone—Headache—Triamcinolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Metolazone—Headache—Methylprednisolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Metolazone—Abdominal pain—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Metolazone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Metolazone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Metolazone—Dizziness—Betamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Metolazone—Dizziness—Dexamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Metolazone—Insomnia—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Metolazone—Nausea—Triamcinolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Metolazone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Metolazone—Nausea—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Metolazone—Somnolence—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Metolazone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Metolazone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Metolazone—Vomiting—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Metolazone—Vomiting—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Metolazone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Metolazone—Rash—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Metolazone—Rash—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Metolazone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Metolazone—Dermatitis—Betamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Metolazone—Fatigue—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Metolazone—Headache—Betamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Metolazone—Headache—Dexamethasone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Metolazone—Asthenia—Prednisone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Metolazone—Pain—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Metolazone—Pruritus—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Metolazone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Metolazone—Diarrhoea—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Metolazone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Metolazone—Nausea—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Metolazone—Nausea—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Metolazone—Urticaria—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Metolazone—Dizziness—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Metolazone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Metolazone—Vomiting—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Metolazone—Rash—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Metolazone—Dermatitis—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Metolazone—Headache—Prednisone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Metolazone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Metolazone—Asthenia—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Metolazone—Nausea—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Metolazone—Pruritus—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Metolazone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Metolazone—Dizziness—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Metolazone—Vomiting—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Metolazone—Rash—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Metolazone—Dermatitis—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Metolazone—Headache—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Metolazone—Nausea—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
